Finance

Beta
Lists
APOLLOHOSP:NSE
Apollo Hospitals Enterprise Ltd
₹8,314.50
+0.79%
(+65.50) 1D
Jun 5, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for APOLLOHOSP...
Open
₹8,265.00
High
₹8,341.00
Low
₹8,240.00
Mkt. cap
1.19T
Avg. vol.
436.21K
Volume
187.97K
Dividend
0.24%
Quarterly dividend
₹5.00
Ex-dividend date
Feb 16, 2026
P/E ratio
61.62
52-wk high
₹8,443.00
52-wk low
₹6,696.50
EPS
₹134.94
Shares outstanding
139.13M
No. of employees
42K
Open
₹8,265.00
High
₹8,341.00
Low
₹8,240.00
Mkt. cap
1.19T
Avg. vol.
436.21K
Volume
187.97K
Dividend
0.24%
Quarterly dividend
₹5.00
Ex-dividend date
Feb 16, 2026
P/E ratio
61.62
52-wk high
₹8,443.00
52-wk low
₹6,696.50
EPS
₹134.94
Shares outstanding
139.13M
No. of employees
42K
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to APOLLOHOSP in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for APOLLOHOSP in the last 3 months.
Highest
Current ₹8,314.50
₹9,700.00 (+16.66%)
Average
₹9,700.00 (+16.66%)
Lowest
₹9,700.00 (+16.66%)
News stories
From sources across the web
Profile
Apollo Hospitals Enterprise Limited is an Indian multinational healthcare group headquartered in Chennai. It is the largest for-profit private hospital network in India, with a network of 71 owned and managed hospitals. Along with the eponymous hospital chain, the company also operates pharmacies, primary care and diagnostic centres, telehealth clinics, and digital healthcare services among others through its subsidiaries. The company was founded by Prathap C. Reddy in 1983 as the first corporate healthcare provider in India. Several of Apollo's hospitals have been among the first in India to receive international healthcare accreditation by the America-based Joint Commission International as well as NABH accreditation. Wikipedia
About Apollo Hospitals Enterprise Ltd
CEO-
Employees42.5K
FoundedSep 18, 1983
Headquarters-
SectorHealth care provider
Websiteapollohospitals.com
Last report
May 21, 2026
Fiscal period
Q4 2026
EPS / Est. (INR)
₹36.76 / ₹33.02
+11.32%beat
Revenue / Est. (INR)
66.06B / 64.72B
+2.06%beat
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
58.42B
63.04B
64.77B
66.06B
Cost of goods sold
37.60B
40.10B
41.31B
41.74B
Cost of revenue
37.60B
40.10B
41.31B
41.74B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
-
Operating expense
14.45B
15.70B
16.00B
16.45B
Total operating expenses
52.05B
55.80B
57.31B
58.19B
Operating income
6.37B
7.23B
7.46B
7.87B
Other non operating income
402.00M
547.00M
528.00M
439.00M
EBT including unusual items
5.83B
6.75B
6.82B
7.22B
EBT excluding unusual items
5.83B
6.75B
7.01B
7.22B
Income tax expense
1.42B
1.81B
1.66B
1.70B
Effective tax rate
24.32%
26.78%
24.30%
23.59%
Other operating expenses
12.30B
13.52B
13.81B
14.20B
Net income
4.33B
4.77B
5.02B
5.29B
Net profit margin
7.41%
7.57%
7.75%
8.01%
Earnings per share
30.10
33.19
35.95
36.76
Interest and investment income
-
-
-
-
Interest expense
-1.08B
-1.10B
-1.13B
-1.19B
Net interest expenses
-1.08B
-1.10B
-1.13B
-1.19B
Depreciation and amortization charges
2.15B
2.18B
2.19B
2.24B
EBITDA
7.68B
9.40B
8.77B
10.06B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer